Stavroula Kyriazi1,2, David J. Collins1,
Veronica A. Morgan2, Sharon L. Giles2, Nandita M.
deSouza1,2
1CR-UK and EPSRC Cancer Imaging Centre,
Institute of Cancer Research, Sutton, Surrey, United Kingdom; 2Royal
Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Conventional
biochemical and morphological criteria of chemotherapy efficacy in metastatic
ovarian cancer are not sensitive in the early course of treatment and fail to
reflect the frequently seen intra-patient differential response according to
anatomical site of disease. The present study examines the value of
Diffusion-Weighted Imaging in the early assessment of site-specific
(peritoneal vs omental) chemotherapy response in ovarian-related
carcinomatosis.